Enzo Biochem Inc/ US2941001024 /
| 2024-04-26 10:10:00 PM | Chg. -0.02 | Volume | Bid10:00:00 AM | Ask10:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.05USD | -1.87% | 114,913 Turnover: 112,696.40 |
1.03Bid Size: 9,700 | 1.29Ask Size: 100 | 53.79 mill.USD | - | 2.56 |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 7.7300 | 7.9480 | 8.2140 | 7.9010 | 7.6360 | ||||||
| Intangible Assets | 8.1080 | 6.1550 | 4.4220 | 2.8950 | 1.8860 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 23.6750 | 21.9080 | 20.4240 | 18.5810 | 18.4600 | ||||||
| Inventories | 8.6900 | 7.3960 | 6.9710 | 7.0470 | 7.2780 | ||||||
| Accounts Receivable | 12.4700 | 12.1090 | 14.5920 | 15.1800 | 13.1470 | ||||||
| Cash and Cash Equivalents | 17.4550 | 18.1090 | 67.7770 | 64.1670 | 60.0410 | ||||||
| Current Assets | 40.7360 | 46.4860 | 91.3970 | 89.0840 | 83.2000 | ||||||
| Total Assets | 64.4110 | 68.3940 | 111.8210 | 107.6650 | 101.6600 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 8.2450 | 8.7620 | 9.8570 | 10.3500 | 9.5160 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 13.1000 | 11.3400 | 8.2000 | 6.7000 | 10.1000 | ||||||
| Liabilities | 27.4610 | 25.7880 | 22.2670 | 18.7930 | 20.5390 | ||||||
| Share Capital | .4430 | .4610 | .4630 | - | .4720 | ||||||
| Total Equity | 36.9500 | 42.6060 | 89.5540 | 88.8720 | 81.1210 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 64.4110 | 68.3940 | 111.8210 | 107.6650 | 101.6600 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 95.9470 | 97.5990 | 102.7730 | 107.8040 | 104.7130 | ||||||
| Depreciation (total) | 3.9710 | 3.7890 | 3.8400 | 3.5980 | 3.1300 | ||||||
| Operating Result | -10.1800 | -1.2060 | 47.0030 | -3.0660 | -12.1640 | ||||||
| Interest Income | -.2080 | -.2450 | -.1360 | .3840 | .8530 | ||||||
| Income Before Taxes | -9.9050 | -2.2920 | 46.5150 | -2.4220 | -11.4180 | ||||||
| Income Taxes | .0720 | -.0070 | 1.2290 | .0820 | -1.0970 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -9.9770 | -2.2850 | 45.2860 | -2.5040 | -10.3210 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -1.6970 | -3.7000 | 53.1260 | -.2050 | -2.7350 | ||||||
| Cash Flow from Investing Activities | -.8330 | -1.7520 | -1.5120 | -1.7490 | -1.9440 | ||||||
| Cash Flow from Financing | 10.9170 | 6.2250 | -1.9310 | -1.6690 | .5590 | ||||||
| Decrease / Increase in Cash | 8.4480 | .6540 | 49.6680 | -3.6100 | -4.1260 | ||||||
| Employees | 475 | 483 | 489 | 472 | 460 | ||||||
